Tibor G.
- Country
- Hungary
- Department
- Department of Gastroenterology Podmaniczky u. 111.
Research Overview
- Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial
- Efficacy and Safety of Linaprazan Glurate versus Lansoprazole for Maintenance of Healing in Patients with Healed Erosive Esophagitis Due to Gastroesophageal Reflux Disease
- Long‑Term Safety and Efficacy of SPY001‑001 Monotherapy and Combination Therapy with Long‑Acting Antibodies in Adults with Ulcerative Colitis
Data & Insights
Has run more than one trial at 436 of 960 partner sites.
Specializations
Cardiovascular disease and heart failure
Gábor Duray’s clinical research activity includes a strong focus on atherosclerotic cardiovascular disease, acute coronary syndrome, myocardial infarction, and broader heart failure syndromes, including HFpEF, HFrEF, and worsening or decompensated presentations.
- ASCVD and elevated lipoprotein(a)
- Acute coronary syndrome and ischemic stroke prevention
- Heart failure with preserved or reduced ejection fraction
- Hypertension and refractory angina
His trial portfolio also extends to cardiomyopathy, pulmonary hypertension, and secondary prevention strategies aimed at reducing major cardiovascular events.
Metabolic and lipid disorders
His therapeutic interests cover type 2 diabetes, obesity, overweight, and severe lipid abnormalities, with attention to cardiometabolic risk reduction and related complications.
- Type 2 diabetes mellitus
- Obesity and excess weight
- Severe hypertriglyceridemia
- Elevated lipoprotein(a)
The research landscape includes therapies targeting glycemic control and lipid-mediated cardiovascular risk in patients with established vascular disease.
Oncology
Gábor Duray is involved in clinical studies across several solid tumor settings, with particular emphasis on breast cancer, urothelial carcinoma, gastric cancer, ovarian cancer, and prostate cancer.
- Hormone receptor-positive, HER2-negative breast cancer
- HER2-positive metastatic breast cancer
- Advanced urothelial cancer
- Metastatic gastric cancer and advanced ovarian cancer
His oncology portfolio also includes head and neck squamous cell carcinoma, triple-negative breast cancer, and other advanced solid malignancies.
Immune-mediated and gastrointestinal diseases
His research activity includes inflammatory and immune-driven conditions such as Crohn’s disease, ulcerative colitis, and psoriatic arthritis, reflecting interest in chronic inflammatory disease management.
- Crohn’s disease and fistulizing disease
- Ulcerative colitis
- Psoriatic arthritis
- Primary biliary cholangitis
The portfolio also includes short bowel syndrome and gastroesophageal reflux disease-related esophageal inflammation.
Ophthalmology and hematologic disorders
His clinical trial involvement spans retinal and visual disorders such as wet age-related macular degeneration, diabetic macular edema, and geographic atrophy, alongside inherited bleeding disorders.
- Neovascular age-related macular degeneration
- Diabetic macular edema
- Geographic atrophy
- Hemophilia A and hemophilia B
Additional interests include acquired blepharoptosis and long-term management of bleeding risk in patients with coagulation disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.